4D Printing in Healthcare Segmentation
Technology (Shape-Memory Polymers, Programmable Hydrogels, Smart Alloys, 4D Bioprinting)
Based on technology, the shape memory polymers segment is expected to garner the highest share of 42.5% in the 4D printing in healthcare market by the end of 2037. The dominance of the segment is attributable to its unique capability to remember and return to pre-programmed shapes when exposed to particular stimuli, such as body temperature. In this context, FDA reports it has approved more than 15 4D printed shape memory vascular stents since 2023, which demonstrated more than 90% success rates in clinical trials, marking a higher success rate than nitinol stents. Furthermore, the Smart Materials for Medical Devices program by NIH states that these polymers offer 30% faster patient recovery by appreciably lowering vessel trauma during deployment.
Application (Cardiovascular Implants, Orthopedic Devices, Drug Delivery Systems, Tissue Engineering, Surgical Tools)
Based on application, the cardiovascular implants segment is projected to grow with a lucrative share of 38.3% in the 4D printing in healthcare market during the forecast period. The growth in the segment is subject to the needs of the global geriatric population, reimbursement expansion, and clinical efficacy. The CDC in 2024 estimates that 500,000 annual heart valve replacements are performed in the U.S. demand growing at 7%. Besides, the CMS added 6 new 4D-printed valve reimbursement codes, offering $19,000-$26,000 per procedure. Furthermore, these 4D-printed valves adapt to anatomical changes over time, thereby reducing reoperation rates by 60% in terms of pediatric cases.
Our in-depth analysis of the 4D printing in healthcare market includes the following segments:
|
Technology |
|
|
Application |
|
|
End User |
|
